Navigation Links
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy
Date:8/14/2014

technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Forward Looking Statements

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and statements regarding the company's clinical development of KB001-A, KB004 and KB003. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the potential timing and outcomes of clinical studies of KB001-A and KB004 undertaken now or in the future; the potential, if any, for future development of KB003; the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's dependence on Sanofi Pasteur for the manufacture, development and commercialization of KB001-A; the company's ability to successfully progress or complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
2. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
3. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
4. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
5. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
6. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
7. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
8. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
9. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
10. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
11. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ), a ... with an emphasis on the treatment of primary and ... months ended March 31, 2015.  Highlights ... , Achieved quarterly product revenue of $0.44 million, an ... quarter of 2014; , Activated a prospective patient ...
(Date:5/6/2015)... NEW YORK , May 6, 2015 /PRNewswire/ ... patient activation and patient-reported outcomes for chronic pain, ... report released by The Bravewell Collaborative ... by the Patients Receiving Integrative Medicine Interventions Effectiveness ... medicine. Using data from PRIMIER ...
(Date:5/6/2015)... The Parenteral Drug Association (PDA) Board of ... Richard M. Johnson to continue as President ... pleased to have Richard Johnson continue as ... the Chair of the Board of Directors. "Under Richard,s ... has led a strong staff and dedicated volunteers, hosting ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2
... organizations and individuals across the country and around the ... 1, 2007. Since 1988,World AIDS Day has provided countless ... reinvigorate global, national, regional,and local efforts to stop AIDS., ... Day is leadership. Nearly 27,years since it was first ...
... to Conduct Conference Call on, December 10, 2007 to Discuss ... ... Data, SOUTH SAN FRANCISCO, Calif., Nov. 29 Sunesis,Pharmaceuticals, Inc. ... today announced that it,will present data on the company,s two lead ...
Cached Medicine Technology:AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic 2Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology 3
(Date:5/6/2015)... FL- May 05, 2014 (PRWEB) May 06, 2015 ... Grant Lock accepted, on behalf of MEBC, an ... organizations from JDA Software during FOCUS 2015, JDA’s ... attendees across the manufacturing, retail and wholesale distribution ... ensuring that their clients are receiving services that ...
(Date:5/6/2015)... 06, 2015 Baptist Medical Center ... first in north Florida and southeast Georgia region ... latest innovation in total hip replacement surgery performed ... robotic arm that enables the accurate alignment and ... has offered MAKOplasty® partial knee resurfacing using the ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of ... coolest applications on the market for iOS, Android, and Windows. Joe ... review and shared with viewers how this application walks users through ... a good navigator people had to know how to read a ... master navigator. Well what if people could “GPS” their way through ...
(Date:5/6/2015)... Anitha Nallari, MD has joined ... Inc. in Columbus, OH. Dr. Nallari will see patients ... in breast cancer, lung cancer, GI and gallbladder cancer, head ... benign hematology. , Dr. Anitha Nallari is Board ... American Board of Internal Medicine. She completed her medical education ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... hand sanitizers are increasing, driven by the rising consumer ... the spread of contagious diseases. Hand washing is becoming ... of consumer apprehension over contracting infections. Periodic outbreak of ... the recent Ebola virus disease (EVD) epidemic ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4
... Blacksburg, Va. Researchers from the Virginia Bioinformatics Institute ... a large family of virulence proteins in oomycete plant ... of their hosts. The protein region contains the amino ... ability to carry the virulence proteins across the membrane ...
... Comparison Tool Gives Anthem Members in Colorado,s metro, ... with Medical Procedures, DENVER, Aug. 4 ... today the launch of its industry-leading transparency,initiative. Now, ... Anthem,Care Comparison, an online tool that provides total ...
... Cancellation of New Medicare Regulation Protects,Texas Seniors, Access ... The Texas Health Care,Association (THCA) today thanked ... E.B. Johnson (D-TX) for helping to lead a,successful, ... Administration,from moving forward with a new regulation that ...
... a rewards club and medication review ... ... operated Sav-Mor Drug Stores has officially introduced the Prescription,Rewards Club, a discount ... Working with their suppliers, Sav-Mor has responded to competitors, $4,generic drug ...
... The methods mothers use to control their children during playtime ... their child,s self-esteem and behavior, according to a new Purdue ... interact with their children based on one study, but what ... for being verbally aggressive have a tendency to try to ...
... Inc. (NYSE: WLP ) today,announced the appointment ... Senior,Business and Consumer Business marketing, effective immediately., ... for leading WellPoint,s,Medicare business division and Consumer Business ... from the unique knowledge of,Medicare and marketing that ...
Cached Medicine News:Health News:Key to virulence protein entry into host cells discovered 2Health News:Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado 2Health News:Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado 3Health News:U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts 2Health News:U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts 3Health News:Michigan-based Company Introduces Discount Prescription Drug Program 2Health News:Study: verbal aggression may affect children's behavior 2Health News:WellPoint Appoints Krista A. Bowers as President of Senior Business 2
... (ECP) is a surgical approach to glaucoma ... laser application. The ciliary body (which produces ... from the anterior or posterior segment, through ... tissues are easily and accurately identified utilizing ...
... Centuries of German Craftsmanship have ... in the world. Ocutek® now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
Medicine Products: